HTB | HIV i-Base

HTB October 2022 (3 October 2022)

Featured HTB October 2022 (3 October 2022) 3 October 2022. Related: Editorial.
Featured HTB September 2022 (1 September 2022) 1 September 2022. Related: Editorial.
Featured Update on monkeypox in the UK: reduced cases, vaccine access, transmission and treatment… 1 September 2022. Related: Special reports, Monkeypox.
Featured HTB August 2022 (3 August 2022) 3 August 2022. Related: Editorial.
Featured In memory: Timothy Ray Brown – the Berlin patient, the first person to be cured of HIV 14 October 2020. Related: In memory.
Better re-suppression after viral rebound with DTG-based ART compared to EFV- or PI-based regimens 1 December 2022. Related: Early access, Conference reports, Treatment strategies, HIV 16 Glasgow 2022.
Vertical transmission rate below 0.3% among women living with HIV in the UK 1 December 2022. Related: Early access, Conference reports, Pregnancy, HIV 16 Glasgow 2022.
Metabolic complications of newer HIV drugs in older people 1 December 2022. Related: Early access, Conference reports, Lipodystrophy and metabolic complications, World AIDS 24 Montreal 2022.
Cabotegravir-LA submitted to EMA for use as PrEP in Europe 1 December 2022. Related: Early access, Antiretrovirals, HIV prevention and transmission.
HIV Glasgow Congress 2022 1 December 2022. Related: Early access, Conference reports, HIV 16 Glasgow 2022.
Monkeypox into Autumn: still no emergency funding, vaccine efficacy and UK declines further vaccines 3 October 2022. Related: Special reports, Monkeypox.
Training webinar: 2nd HIV from A to Z 3 October 2022. Related: On the web, Future meetings.
BHIVA General Medicine Course 2022 3 October 2022. Related: Future meetings.
Supporting Ukraine 3 October 2022. Related: Editorial.
14th International Workshop on HIV & Pediatrics 3 October 2022. Related: Conference reports, Conference index, Intl Paediatrics Workshop 2022.
Switch study for people with insomnia using dolutegravir: still enrolling 3 October 2022. Related: Research studies.
First paediatric pharmacokinetic data of dolutegravir in combination with a TAF-based NRTI backbone 3 October 2022. Related: Conference reports, Paediatric care, Intl Paediatrics Workshop 2022.
24th International AIDS Conference (AIDS 2022): further reports 3 October 2022. Related: Conference reports, Conference index, World AIDS 24 Montreal 2022.
AIDS 2022: Efficacy of DTG- vs EFV-based first-line ART in advanced HIV with CD4 <50 cells/mm3 3 October 2022. Related: Conference reports, Antiretrovirals, Treatment strategies, World AIDS 24 Montreal 2022.
AIDS 2022: Gender-affirming hormones, weight gain and ART 3 October 2022. Related: Conference reports, PK and drug interactions, Side effects, World AIDS 24 Montreal 2022.
Islatravir update: treatment studies to use a lower dose but PrEP research discontinued in favour of MK-8537 3 October 2022. Related: Antiretrovirals.
Low levels of RPV-LA might explain failure with injectable ART despite perfect adherence 3 October 2022. Related: Antiretrovirals, Resistance.
Tecovirimat treatment for monkeypox in the UK: importance of the PLATINUM study 3 October 2022. Related: Monkeypox.
Levels of monkeypox viral load in different body sites supports highest risk from body contact 3 October 2022. Related: Monkeypox.
Severe complication of monkeypox reported to the US CDC: risks associated with HIV and other causes of immunosuppression 3 October 2022. Related: Monkeypox.
New reports on MPX vaccine efficacy suggest protection but cases reported after two shots 3 October 2022. Related: Monkeypox.
Other monkeypox studies of interest 3 October 2022. Related: Monkeypox.
BHIVA, BASHH and other professional organisations publish open letters on the refusal by the UK government to acknowledge monkeypox crisis 3 October 2022. Related: Monkeypox.
Reduced HAND prevalence in large cross-sectional cohort study 3 October 2022. Related: Coinfections and complications.
Update to IAS-USA drug resistance tables 3 October 2022. Related: Resistance.
Future meetings and webinars 2022/2023 3 October 2022. Related: Future meetings.
HTB: no. 10 (3 October 2022) PDF download 3 October 2022. Related: PDFs.
HTB: no. 9 (3 September 2022) PDF download 1 September 2022. Related: PDFs.
24th International AIDS Conference (AIDS 2022) 1 September 2022. Related: Conference reports, Conference index, World AIDS 24 Montreal 2022.
Dolutegravir no longer linked to higher risk of neural tube defects: latest update from the Tsepamo study 1 September 2022. Related: Conference reports, Pregnancy, World AIDS 24 Montreal 2022.
Weight gain with dolutegravir and TAF in ADVANCE study continues out to week 192 1 September 2022. Related: Conference reports, Women's health, World AIDS 24 Montreal 2022.
VRC01 added to early ART in infants did not reduce viral reservoir 1 September 2022. Related: Conference reports, Paediatric care, World AIDS 24 Montreal 2022.
Using PrEP during pregnancy is safe for children 1 September 2022. Related: Conference reports, Pregnancy, Paediatric care, World AIDS 24 Montreal 2022.
Long-acting CAB/RPV injections have a similar weight and lipid profile to dolutegravir-based oral ART 1 September 2022. Related: Conference reports, World AIDS 24 Montreal 2022.
Montreal’s response to monkeypox: rapid vaccine rollout, 39 breakthrough infections 1 September 2022. Related: Conference reports, Monkeypox, World AIDS 24 Montreal 2022.
Summary of 620 cases of monkeypox seen at three London clinics 1 September 2022. Related: Conference reports, Monkeypox, World AIDS 24 Montreal 2022.
Advances in HIV cure-related research: IAS workshop now online 1 September 2022. Related: Conference reports, World AIDS 24 Montreal 2022.
Lenacapavir approved in the EU and UK to treat multidrug resistant HIV 1 September 2022. Related: Antiretrovirals.
US survey reports 50% of gay men changed sexual behaviour to avoid monkeypox 1 September 2022. Related: Monkeypox.
US model limits monkeypox infections by one-third from having fewer one-time partners: short-term strategy until next vaccine supply 1 September 2022. Related: Monkeypox.
BHIVA include efficacy data on HIV and monkeypox vaccine: updated statement (August 2022) 1 September 2022. Related: Monkeypox.
Monkeypox DNA detected in anal samples of asymptomatic men in Paris and Belgium 1 September 2022. Related: Monkeypox.
Unusual case reports: non-sexual acquisition, severe MPX and advanced HIV, human-to-dog transmission 1 September 2022. Related: Monkeypox.
Tecovirimat for treating mild monkeypox: new studies open in the UK and US 1 September 2022. Related: Monkeypox.
US cases: MMWR report on 1891 cases to 22 July 2022 1 September 2022. Related: Monkeypox.
Monkeypox transmission in heterosexual couples in Nigeria 1 September 2022. Related: Monkeypox.
Access to vaccines and treatment for pregnant women at risk of monkeypox 1 September 2022. Related: Monkeypox.